357 related articles for article (PubMed ID: 19760959)
21. [Pro-hepcidin, its relation with indicators of iron metabolism and of inflammation in patients hemodialyzed treated or not with recombinant erythropoietin].
Barrios Y; Espinoza M; Barón MA
Nutr Hosp; 2010; 25(4):555-60. PubMed ID: 20694291
[TBL] [Abstract][Full Text] [Related]
22. Hepcidin, interleukin-6 and hematological iron markers in males before and after heart surgery.
Hoppe M; Lönnerdal B; Hossain B; Olsson S; Nilsson F; Lundberg PA; Rödjer S; Hulthén L
J Nutr Biochem; 2009 Jan; 20(1):11-6. PubMed ID: 18495462
[TBL] [Abstract][Full Text] [Related]
23. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S
Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
[TBL] [Abstract][Full Text] [Related]
24. Regulation of hepcidin: insights from biochemical analyses on human serum samples.
Kemna EH; Kartikasari AE; van Tits LJ; Pickkers P; Tjalsma H; Swinkels DW
Blood Cells Mol Dis; 2008; 40(3):339-46. PubMed ID: 18023212
[TBL] [Abstract][Full Text] [Related]
25. Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study.
Alexander J; Tung BY; Croghan A; Kowdley KV
Liver Int; 2007 Mar; 27(2):268-73. PubMed ID: 17311623
[TBL] [Abstract][Full Text] [Related]
26. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
[TBL] [Abstract][Full Text] [Related]
27. Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
Kronenberger B; Wagner M; Herrmann E; Mihm U; Piiper A; Sarrazin C; Zeuzem S
J Viral Hepat; 2005 May; 12(3):307-14. PubMed ID: 15850472
[TBL] [Abstract][Full Text] [Related]
28. Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease.
Aigner E; Theurl I; Haufe H; Seifert M; Hohla F; Scharinger L; Stickel F; Mourlane F; Weiss G; Datz C
Gastroenterology; 2008 Aug; 135(2):680-8. PubMed ID: 18505688
[TBL] [Abstract][Full Text] [Related]
29. Increased serum hepcidin levels in patients with porphyria cutanea tarda.
Darwich E; To-Figueras J; Molina-López RA; Deulofeu R; Olbina G; Westerman M; Sánchez-Tápias JM; Muñoz-Santos C; Herrero C
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e68-74. PubMed ID: 22429447
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription.
Nishina S; Hino K; Korenaga M; Vecchi C; Pietrangelo A; Mizukami Y; Furutani T; Sakai A; Okuda M; Hidaka I; Okita K; Sakaida I
Gastroenterology; 2008 Jan; 134(1):226-38. PubMed ID: 18166355
[TBL] [Abstract][Full Text] [Related]
31. Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease.
Lee SH; Jeong SH; Park YS; Hwang JH; Kim JW; Kim N; Lee DH
Korean J Hepatol; 2010 Sep; 16(3):288-94. PubMed ID: 20924211
[TBL] [Abstract][Full Text] [Related]
32. Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI).
Sasu BJ; Li H; Rose MJ; Arvedson TL; Doellgast G; Molineux G
Blood Cells Mol Dis; 2010 Oct; 45(3):238-45. PubMed ID: 20800515
[TBL] [Abstract][Full Text] [Related]
33. Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls.
Costa-Matos L; Batista P; Monteiro N; Simões M; Egas C; Pereira J; Pinho H; Santos N; Ribeiro J; Cipriano MA; Henriques P; Girão F; Rodrigues A; Carvalho A
Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1158-65. PubMed ID: 22732356
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of iron status in patients with chronic hepatitis C.
Sartori M; Andorno S; La Terra G; Boldorini R; Leone F; Pittau S; Zecchina G; Aglietta M; Saglio G
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):396-401. PubMed ID: 9789136
[TBL] [Abstract][Full Text] [Related]
35. [The effect of tobacco smoking during pregnancy on concentration of pro-hepcidin and some parameters of iron metabolism in matched-maternal cord pairs].
Chełchowska M; Lewandowski L; Ambroszkiewicz J; Swiatek E; Gajewska J; Ołtarzewski M; Laskowska-Klita T
Przegl Lek; 2008; 65(10):474-8. PubMed ID: 19189526
[TBL] [Abstract][Full Text] [Related]
36. Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy.
Weiss G; Theurl I; Eder S; Koppelstaetter C; Kurz K; Sonnweber T; Kobold U; Mayer G
Eur J Clin Invest; 2009 Oct; 39(10):883-90. PubMed ID: 19563467
[TBL] [Abstract][Full Text] [Related]
37. Influence of Helicobacter pylori infection on iron accumulation in hepatitis C.
Sumida Y; Kanemasa K; Yamaoka Y; Imamura S; Katoh N; Nakashima T; Tachibana S; Mitsuyoshi H; Itoh Y; Okanoue T
Liver Int; 2006 Sep; 26(7):827-33. PubMed ID: 16911465
[TBL] [Abstract][Full Text] [Related]
38. Effect of blood letting on serum aminotransferase levels of patients with chronic hepatitis C and iron overload.
Girelli CM; Mirata C; Casiraghi A
Recenti Prog Med; 1998 May; 89(5):241-4. PubMed ID: 9676130
[TBL] [Abstract][Full Text] [Related]
39. Effect of fluvastatin on serum prohepcidin levels in patients with end-stage renal disease.
Arabul M; Gullulu M; Yilmaz Y; Akdag I; Kahvecioglu S; Eren MA; Dilek K
Clin Biochem; 2008 Sep; 41(13):1055-8. PubMed ID: 18571502
[TBL] [Abstract][Full Text] [Related]
40. Erythrocyte transfusions and serum prohepcidin levels in premature newborns with anemia of prematurity.
Yapakçi E; Ecevit A; Gökmen Z; Tarcan A; Ozbek N
J Pediatr Hematol Oncol; 2009 Nov; 31(11):840-2. PubMed ID: 19816209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]